ARTICLE | Clinical News
AMI data for Genentech's TNKase
August 23, 2001 7:00 AM UTC
Results of DNA's ASSENT 3 open-label international trial in 6,095 heart acute myocardial infarction (AMI) patients showed that the combination of treatment with full-dose TNKase plus Clexane low molec...